Biogen Inc. Common Stock Earnings Dividend

Biogen Inc. Common Stock’s revenue jumped 3.42% since last year same period to $2736Mn in the Q2 2026. On a quarterly growth basis, Biogen Inc. Common Stock has generated 10.42% jump in its revenue since last 3-months.

Biogen Inc. Common Stock’s net profit fell -84.64% since last year same period to $97.5Mn in the Q2 2026. On a quarterly growth basis, Biogen Inc. Common Stock has generated -69.48% fall in its net profits since last 3-months.

Biogen Inc. Common Stock’s net profit margin fell -85.15% since last year same period to 3.56% in the Q2 2026. On a quarterly growth basis, Biogen Inc. Common Stock has generated -72.36% fall in its net profit margins since last 3-months.

Biogen Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 3.04 - a 5.19% jump from last quarter’s estimates.

Biogen Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 3.04.

Biogen Inc. Common Stock’s earning per share (EPS) fell -34.19% since last year same period to 3.6 in the Q2 2026. This indicates that the Biogen Inc. Common Stock has generated -34.19% annual rate of fall in its earning per share (EPS) in the last 4 quarters.